BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16225671)

  • 1. The 3' region of human papillomavirus type 16 early mRNAs decrease expression.
    Vinther J; Rosenstierne MW; Kristiansen K; Norrild B
    BMC Infect Dis; 2005 Oct; 5():83. PubMed ID: 16225671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin.
    Mistry N; Simonsson M; Evander M
    Virol J; 2007 Mar; 4():27. PubMed ID: 17352804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
    Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of inhibitory RNA elements in the late 3'-untranslated region is a conserved property of human papillomaviruses.
    Zhao X; Rush M; Carlsson A; Schwartz S
    Virus Res; 2007 May; 125(2):135-44. PubMed ID: 17250918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral interaction: a possible contributing factor in head and neck cancer progression.
    Underbrink MP; Hoskins SL; Pou AM; Albrecht T
    Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation enhancer in the 3'-untranslated region of rotavirus gene 6 mRNA promotes expression of the major capsid protein VP6.
    Yang AD; Barro M; Gorziglia MI; Patton JT
    Arch Virol; 2004 Feb; 149(2):303-21. PubMed ID: 14745597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HPV transcriptome in HPV16 positive cell lines.
    Schmitt M; Pawlita M
    Mol Cell Probes; 2011; 25(2-3):108-13. PubMed ID: 21439369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells.
    Donalisio M; Cornaglia M; Landolfo S; Lembo D
    Virus Res; 2008 Mar; 132(1-2):253-6. PubMed ID: 18206261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oncolytic mutant of herpes simplex virus type-1 in which replication is governed by a promoter/enhancer of human papillomavirus type-16.
    Griffith C; Noonan S; Lou E; Shillitoe EJ
    Cancer Gene Ther; 2007 Dec; 14(12):985-93. PubMed ID: 17853922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of cellular microRNAs in HPV 11, -16, and -45 transfected cells.
    Dreher A; Rossing M; Kaczkowski B; Andersen DK; Larsen TJ; Christophersen MK; Nielsen FC; Norrild B
    Biochem Biophys Res Commun; 2011 Aug; 412(1):20-5. PubMed ID: 21782796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
    Luczak MW; Jagodzinski PP
    Cancer Lett; 2008 Dec; 272(1):53-60. PubMed ID: 18687520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis.
    Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated HPV genomes tend to integrate in gene desert areas in the CaSki, HeLa, and SiHa cervical cancer cell lines.
    Diao MK; Liu CY; Liu HW; Li JT; Li F; Mehryar MM; Wang YJ; Zhan SB; Zhou YB; Zhong RG; Zeng Y
    Life Sci; 2015 Apr; 127():46-52. PubMed ID: 25747255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
    Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
    Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of splicing-associated SR proteins by HPV-16.
    Mole S; Veerapraditsin T; McPhillips MG; Graham SV
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1145-7. PubMed ID: 17073771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cells.
    Márquez-Gutiérrez MA; Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
    Arch Med Res; 2007 Oct; 38(7):730-8. PubMed ID: 17845891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a novel reporter assay for human papillomavirus type 16 late gene expression.
    Orrù B; Cunniffe C; Ryan F; Schwartz S
    J Virol Methods; 2012 Aug; 183(2):106-16. PubMed ID: 22484615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.